Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3428]
News [7862]
Articles [63]
Editorials [9]
Conferences [212]
elearning [49]
Prophylactic gastrectomy in CDH1 mutation
Prof. Franco Roviello - University of Siena, Italy
Prophylactic gastrectomy in CDH1 mutation ( Prof. Franco Roviello - University of Siena, Italy )
22 Jul 2020
Pathology of diffuse gastric cancer with CDH1 mutation
Prof. Fàtima Carneiro - University of Porto, Portugal
Pathology of diffuse gastric cancer with CDH1 mutation ( Prof. Fàtima Carneiro - University of Porto, Portugal )
22 Jul 2020
Lung cancer updates from ASCO 2020
Dr Luis Raez - Memorial Cancer Institute, Florida, USA
Lung cancer updates from ASCO 2020 ( Dr Luis Raez - Memorial Cancer Institute, Florida, USA )
17 Jul 2020
Who does the work in cancer control?
Dr Nazik Hammad - Queen's University, Kingston, Canada
Who does the work in cancer control? ( Dr Nazik Hammad - Queen's University, Kingston, Canada )
17 Jul 2020
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial...
Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial cancer ( Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA )
30 Jun 2020
Checkmate 9LA: Nivolumab, ipilimumab and chemotherapy for stage IV NSCLC
Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Checkmate 9LA: Nivolumab, ipilimumab and chemotherapy for stage IV NSCLC ( Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
30 Jun 2020
New CAR T therapy for relapsed and refractory ALL
Dr Claire Roddie - University College London, London, UK
New CAR T therapy for relapsed and refractory ALL ( Dr Claire Roddie - University College London, London, UK )
25 Jun 2020
IKEMA: Carfilzomib and dexamethasone plus isatuximab for r/r multiple myeloma
Prof Philippe Moreau - University of Nantes, Nantes, France
IKEMA: Carfilzomib and dexamethasone plus isatuximab for r/r multiple myeloma ( Prof Philippe Moreau - University of Nantes, Nantes, France )
25 Jun 2020
The NEUF study: Treatment of r/r Philadelphia chromosome-positive ALL with...
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
The NEUF study: Treatment of r/r Philadelphia chromosome-positive ALL with blinatumomab ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )
23 Jun 2020
BLIN-01: Blinatumomab for high-risk, Philadelphia chromosome-negative acute...
Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain
BLIN-01: Blinatumomab for high-risk, Philadelphia chromosome-negative acute lymphoblastic leukaemia ( Dr Josep Ribera - Catalan Institute of Oncology, Barcelona, Spain )
23 Jun 2020
Preclinical models for small-cell lung cancer
Prof Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands
Preclinical models for small-cell lung cancer ( Prof Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands )
18 Jun 2020
Early safety from a trial of talimogene laherparepvec (T-VEC) injected into...
Prof J. Randy Hecht - UCLA Jonsson Comprehensive Cancer Center, Santa Monica...
Early safety from a trial of talimogene laherparepvec (T-VEC) injected into liver tumours plus pembrolizumab ( Prof J. Randy Hecht - UCLA Jonsson Comprehensive Cancer Center, Santa Monica, USA )
17 Jun 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation